DNAシーケンスの市場規模、シェア、予測、動向分析：製品別、技術別、用途別、エンドユーザー別 - 2031年までの世界予測

世界のDNAシーケンス市場は、2024年から2031年までのCAGRが11.8%で、2031年までに213億米ドルに達すると予測されます。

広範な2次調査と1次調査、および市場シナリオの詳細な分析を経て、当レポートは主要な業界促進要因、抑制要因、課題、および機会の分析で構成されています。

DNAシーケンス市場の成長は、シーケンスにかかるコストの低下、がんや遺伝性疾患の罹患率の上昇、診断や個別化医療におけるDNAシーケンスの利用の高まり、医薬品研究開発投資の増加、有利な規制・償還政策、高額なヘルスケア支出、シーケンス技術の進歩、臨床・研究用途におけるシーケンス技術の利用促進を目的とした政府の支援イニシアティブなど、いくつかの要因によって牽引されています。しかし、シーケンス消耗品のコストが高いこと、精密医療のための実用的な変異の同定が限定的であること、DNAシーケンスに基づく診断に関連する倫理的・法的懸念などの要因が、この成長を抑制しています。

さらに、DNAシーケンスの用途の拡大、広範なゲノムプロジェクトに対する政府の支援、標的治療に対する意識の高まりと採用、新興市場の経済成長は、この市場で事業を展開する企業に成長機会を提供すると予想されます。しかし、規制の不確実性、小規模ラボにおける専門知識とシーケンス能力の限界、新興国市場におけるシーケンス専門家の不足、NGSインフラに必要な多額の資本は、市場の成長を阻害する課題の一部です。

この市場の主な動向としては、新興DNAシーケンス企業が技術の進歩とコスト削減に注力していること、大手企業がポータブルおよびリアルタイムシーケンス技術の開発に重点を置いていることなどが挙げられます。

本レポートでは、主要企業の製品ポートフォリオと地域情勢別プレゼンス、および過去数年間（2021年～2024年）に各社が採用した主要成長戦略の広範な評価に基づく競合情勢を提供しています。世界のDNAシーケンス市場で事業を展開している主要企業は、Illumina, Inc.（米国）、Thermo Fisher Scientific Inc.（米国）、F. Hoffmann-La Roche Ltd.（スイス）、Revvity, Inc.（スイス）、Revvity, Inc.（米国）、QIAGEN N.V.（オランダ）、Agilent Technologies, Inc.（米国）、Pacific Biosciences of California, Inc.（米国）、Danaher Corporation（米国）、Bio-Rad Laboratories, Inc.（米国）、Oxford Nanopore Technologies Plc.（英国）、MGI Tech Co.Ltd.（中国）です。

本レポートで調査した製品のうち、2024年には消耗品セグメントがDNAシーケンス市場を独占し、総シェアの73.4%を占めると予測されます。この大きな市場シェアは、エンドユーザーからの消耗品に対する需要の高まり、サンプル調製材料の頻繁な使用、手頃な価格の増加、ゲノムマッピングプログラムの拡大に起因しています。

本レポートで調査した用途のうち、2024年には研究およびその他の用途分野がDNAシーケンス市場を独占し、総シェアの67.2%を占めると予測されます。この大きな市場シェアの背景には、シーケンス手法のコスト低下、製薬企業やバイオテクノロジー企業による創薬への研究開発投資の増加、さまざまな臨床および研究環境におけるNGSの利用拡大、薬理学的標的の同定、治療仮説の検証、分子部位を標的とする阻害化合物の潜在的な安全性評価へのインフォマティクスソリューションの応用といった要因があります。

本レポートで調査したエンドユーザーのうち、2024年には製薬・バイオテクノロジー企業セグメントがDNAシーケンス市場を独占し、総シェアの44.7%を占めると予測されます。この大きな市場シェアは、製薬・バイオテクノロジー企業による研究開発費の増加や、慢性疾患の蔓延が次世代シーケンサー製品の採用に拍車をかけていることに起因しています。

世界のDNAシーケンス市場の地域別シナリオの詳細分析では、5つの主要地域（北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ）の詳細な質的・量的洞察と、各地域の主要国のカバレッジを提供しています。2024年には、北米が総シェアの49.0%を占め、市場を独占すると予測されています。また、2024年には米国が北米のDNAシーケンス市場を独占すると予測されています。同地域の市場シェアが大きいのは、ゲノム研究に対する政府の支援策、シーケンスに基づく研究の用途拡大、次世代シーケンス技術の大手プロバイダーの存在、製薬・バイオ製薬企業による研究投資の増加、シーケンスコストの低下、高度なシーケンス製品およびソリューションの幅広い利用可能性、がん罹患率の増加、同地域の有利な償還環境など、いくつかの要因によるものと考えられます。

調査範囲：

DNAシーケンス市場の評価 - 製品別

• 消耗品
  • サンプル調製キットおよび試薬
• DNA抽出および増幅
• 品質管理
• その他のキット・試薬
  • その他の消耗品
• 装置
• ソフトウェア
• サービス

注：その他のキットおよび試薬には、希釈バッファー、DNA標準、DNAクリーンアップ用試薬、ターゲット濃縮用試薬、その他の試薬が含まれます。

DNAシーケンス市場の評価 - 技術別

• 次世代シーケンス
  • 合成によるシーケンス
  • イオン半導体シーケンス
  • DNAナノボールシーケンス
  • 1分子リアルタイムシーケンス
  • その他のNGS技術
• サンガーシーケンスおよびパイロシーケンス

注：その他のNGS技術ナノポアシーケンスとAVITIシーケンス

DNAシーケンス市場の評価 - 用途別

• 研究およびその他の用途
  • 創薬
  • 農業・動物研究
  • その他の用途
• 臨床応用
  • 生殖医療
  • 腫瘍学
  • 感染症
  • その他の臨床応用

注：その他の用途には、食品微生物学、飲食品産業における微生物叢分析、環境調査が含まれます。

注：その他の臨床応用には、神経疾患、希少疾患、代謝および免疫疾患における遺伝子異常の検出が含まれます。

DNAシーケンス市場の評価 - エンドユーザー別

• 製薬企業およびバイオテクノロジー企業
• 病院および診断研究所
• 学術機関および研究センター
• その他のエンドユーザー

注：その他のエンドユーザーには、法医学研究所およびセキュリティ機関、飲食品会社、農業会社などが含まれます。

DNAシーケンス市場の評価 - 地域別

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • フランス
  • イタリア
  • 英国
  • スペイン
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
• 中東・アフリカ

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場洞察

• 概要
• 市場成長への影響要因
  • 市場力学の影響分析
  • 要因分析
• 価格分析
• 業界動向
  • 新興DNAシーケンス企業が技術の向上とコスト削減に注力
  • 主要市場企業のPorTableおよびリアルタイムシーケンス技術への注力
• 規制分析
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東
• ポーターのファイブフォース分析

第5章 DNAシーケンス市場の評価：製品別

• 概要
• 消耗品
  • サンプル調製キットおよび試薬
  • その他の消耗品
• 装置
• ソフトウェア
• サービス

第6章 DNAシーケンスの世界市場の評価：技術別

• 概要
• 次世代シーケンス
  • 合成によるシーケンス
  • イオン半導体シーケンス
  • 1分子リアルタイムシーケンス
  • DNAナノボールシーケンス
  • その他のNGSシーケンス技術
• サンガーシーケンスとパイロシーケンス

第7章 DNAシーケンス市場の評価：用途別

• 概要
• 研究およびその他の用途
  • 創薬
  • 農業・動物研究
  • その他の用途
• 臨床応用
  • 腫瘍学
  • 生殖医療
  • 感染症
  • その他の臨床応用

第8章 DNAシーケンス市場の評価：エンドユーザー別

• 概要
• 製薬企業およびバイオテクノロジー企業
• 病院・診断研究所
• 学術・研究機関
• その他のエンドユーザー

第9章 DNAシーケンス市場の評価：地域別

• 概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
• 中東・アフリカ

第10章 競合分析

• 概要
• 主要成長戦略
• 競合ベンチマーキング
• 競合ダッシュボード
  • 業界リーダー
  • 市場差別化要因
  • 先行企業
  • 新興企業
• 市場シェア分析（2023年）
  • Illumina, Inc.（U.S.）
  • Thermo Fisher Scientific Inc.（U.S.）
  • MGI Tech Co., Ltd.（China）
  • Agilent Technologies, Inc.（U.S.）
  • QIAGEN N.V.（Netherlands）

第11章 企業プロファイル（企業概要、財務概要、製品ポートフォリオ、戦略的展開、SWOT分析）

• Illumina, Inc.（U.S.）
• Thermo Fisher Scientific Inc.
• QIAGEN N.V.
• Agilent Technologies, Inc.
• MGI Tech Co., Ltd.
• F. Hoffmann-La Roche Ltd
• Revvity, Inc.
• Pacific Biosciences of California Inc.
• Danaher Corporation
• Bio-Rad Laboratories, Inc.
• Oxford Nanopore Technologies Plc.
• Other Companies

第12章 付録

LIST OF TABLES

• Table 1 Number of New Cancer Cases, by Type, 2022 VS. 2040
• Table 2 Common Genetic Disorders: Rates of Occurrence
• Table 3 Major Genome Sequencing Projects, by Country
• Table 4 Health Expenditure, by Country
• Table 5 DNA Sequencing Kits & Reagents: Pricing
• Table 6 DNA Sequencing Instruments: Product Description & Pricing
• Table 7 G4 Specifications
• Table 8 UG 100 Specifications
• Table 9 AVITI Specifications
• Table 10 Regulatory Authorities Governing In Vitro Diagnostics, by Country/REGION
• Table 11 Global DNA Sequencing Market, by Offering, 2022-2031 (USD Million)
• Table 12 Global DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 13 Global DNA Sequencing Consumables Market, by Country/Region, 2022-2031 (USD Million)
• Table 14 Global Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
• Table 15 Global Sample Preparation Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
• Table 16 Global Library Preparation Market, by Country/Region, 2022-2031 (USD Million)
• Table 17 Global DNA Extraction & Amplification Consumables Market, by Country/Region, 2022-2031 (USD Million)
• Table 18 Global Quality Control Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
• Table 19 Global Other Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
• Table 20 Global Other Consumables Market, by Country/Region, 2022-2031 (USD Million)
• Table 21 Some of the Companies offering NGS Instruments for DNA Sequencing Are As Follows:
• Table 22 Global DNA Sequencing Instruments Market, by Country/Region, 2022-2031 (USD Million)
• Table 23 Key Players Offering DNA Sequencing Software
• Table 24 Global DNA Sequencing Software Market, by Country/Region, 2022-2031 (USD Million)
• Table 25 Key Players Offering Instrument-related Services
• Table 26 Global DNA Sequencing Services Market, by Country/Region, 2024-2031 (USD Million)
• Table 27 Global DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 28 Global NGS-Based Market, by Technology, 2022-2031 (USD Million)
• Table 29 Global NGS Market, by Country/Region, 2022-2031 (USD Million)
• Table 30 Global Sequencing by Synthesis Market for NGS, by Country/Region, 2022-2031 (USD Million)
• Table 31 Global Ion Semiconductor Sequencing Market for NGS, by Country/Region, 2022-2031 (USD Million)
• Table 32 Global Single-Molecule Real-Time (SMRT) Sequencing Market for NGS, by Country/Region, 2022-2031 (USD Million)
• Table 33 Global DNA Nanoball Sequencing Market for NGS, by Country/Region, 2022-2031 (USD Million)
• Table 34 Global Other NGS Sequencing Technologies Market, by Country/Region, 2022-2031 (USD Million)
• Table 35 Global Sanger Sequencing & Pyrosequencing Market for DNA Sequencing, by Country/Region, 2022-2031 (USD Million)
• Table 36 Global DNA Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 37 Global DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 38 Global DNA Sequencing Market for Research & Other Applications, By Country/Region, 2022-2031 (USD Million)
• Table 39 Global DNA Sequencing Market for Drug Discovery, by Country/Region, 2022-2031 (USD Million)
• Table 40 Global DNA Sequencing Market for Agriculture & Animal Research, by Country/Region, 2022-2031 (USD Million)
• Table 41 Global DNA Sequencing Market for Other Applications, by Country/Region, 2022-2031 (USD Million)
• Table 42 GLOBAL DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 43 GLOBAL DNA Sequencing Market for Clinical Applications, by COUNTRY/Region, 2022-2031 (USD Million)
• Table 44 Global DNA Sequencing Market for Oncology, by Country/Region, 2022-2031 (USD Million)
• Table 45 Global DNA Sequencing Market for Reproductive Health, by Country/Region, 2022-2031 (USD Million)
• Table 46 HIV Prevalence among Adults, by REGION (2020 VS. 2022) (In Million)
• Table 47 Global DNA Sequencing Market for Infectious Diseases, by Country/Region, 2022-2031 (USD Million)
• Table 48 Global DNA Sequencing Market for Other Clinical Applications, by Country/Region, 2022-2031 (USD Million)
• Table 49 Global DNA Sequencing Market, By End User, 2022-2031 (USD Million)
• Table 50 Pharmaceutical Spending in Major Countries
• Table 51 GLOBAL DNA Sequencing Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022-2031 (USD Million)
• Table 52 GLOBAL DNA Sequencing Market for Hospitals & Diagnostic Laboratories, by Country/Region, 2022-2031 (USD Million)
• Table 53 Global DNA Sequencing Market for Academic & Research Institutes, by Country/Region, 2022-2031 (USD Million)
• Table 54 Global DNA Sequencing Market for Other End Users, by Country/Region, 2022-2031 (USD Million)
• Table 55 Global DNA Sequencing Market, by Country/Region, 2022-2031 (USD Million)
• Table 56 North America: DNA Sequencing Market, by Country, 2022-2031 (USD Million)
• Table 57 North America: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
• Table 58 North America: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 59 North America: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
• Table 60 North America: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 61 North America: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 62 North America: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 63 North America: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 64 North America: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 65 North America: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 66 U.S.: Key Macroindicators & Microindicators
• Table 67 U.S.: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
• Table 68 U.S.: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 69 U.S.: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
• Table 70 U.S.: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 71 U.S.: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 72 U.S.: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 73 U.S.: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 74 U.S.: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 75 U.S.: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 76 Some of The Key Active Genomic Projects In Canada, Along With Their Total Investments and Genome Canada Contributions, Are As Follows:
• Table 77 Canada: Key Macroindicators & Microindicators
• Table 78 Canada: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
• Table 79 Canada: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 80 Canada: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
• Table 81 Canada: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 82 Canada: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 83 Canada: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 84 Canada: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 85 Canada: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 86 Canada: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 87 Europe: DNA Sequencing Market, by Country/Region, 2022-2031 (USD Million)
• Table 88 Europe: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
• Table 89 Europe: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 90 Europe: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
• Table 91 Europe: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 92 Europe: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 93 Europe: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 94 Europe: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 95 Europe: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 96 Europe: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 97 Germany: Key Macroindicators & Microindicators
• Table 98 Germany: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
• Table 99 Germany: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 100 Germany: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
• Table 101 Germany: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 102 Germany: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 103 Germany: DNA Sequencing Market, by APPLICATION, 2022-2031 (USD Million)
• Table 104 Germany: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 105 Germany: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 106 Germany: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 107 France: Key Macroindicators & Microindicators
• Table 108 France: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
• Table 109 France: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 110 France: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
• Table 111 France: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 112 France: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 113 France: DNA Sequencing Market, by APPLICATION, 2022-2031 (USD Million)
• Table 114 France: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 115 France: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 116 France: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 117 U.K.: Key Macroindicators & Microindicators
• Table 118 U.K.: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
• Table 119 U.K.: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 120 U.K.: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
• Table 121 U.K.: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 122 U.K.: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 123 U.K.: DNA Sequencing Market, by APPLICATION, 2022-2031 (USD Million)
• Table 124 U.K.: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 125 U.K.: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 126 U.K.: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 127 Italy: Key Macroindicators & Microindicators
• Table 128 Italy: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
• Table 129 Italy: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 130 Italy: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
• Table 131 Italy: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 132 Italy: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 133 Italy: DNA Sequencing Market, by APPLICATION, 2022-2031 (USD Million)
• Table 134 Italy: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 135 Italy: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 136 Italy: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 137 Spain: Key Macroindicators & Microindicators
• Table 138 Spain: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
• Table 139 Spain: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 140 Spain: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
• Table 141 Spain: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 142 Spain: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 143 Spain: DNA Sequencing Market, by APPLICATION, 2022-2031 (USD Million)
• Table 144 Spain: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 145 Spain: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 146 Spain: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 147 Number of Sequences In Each Phase and Other Related Sequencing Information:
• Table 148 ROE: Estimated Number of New Cancer Cases, by Country, 2022 VS. 2030
• Table 149 Rest of Europe: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
• Table 150 Rest of Europe: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 151 Rest of Europe: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
• Table 152 Rest of Europe: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 153 Rest of Europe: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 154 Rest of Europe: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 155 Rest of Europe: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 156 Rest of Europe: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 157 Rest of Europe: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 158 Asia-Pacific: DNA Sequencing Market, by Country/Region, 2022-2031 (USD Million)
• Table 159 Asia-Pacific: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
• Table 160 Asia-Pacific: DNA Sequencing Kits & Reagents Market, by Type, 2022-2031 (USD Million)
• Table 161 Asia-Pacific: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
• Table 162 Asia-Pacific: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 163 Asia-Pacific: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 164 Asia-Pacific: DNA Sequencing Market, by APPLICATION, 2022-2031 (USD Million)
• Table 165 Asia-Pacific: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 166 Asia-Pacific: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 167 Asia-Pacific: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 168 China: Key Macroindicators & Microindicators
• Table 169 China: DNA Sequencing Market, by Offering, 2022-2031 (USD Million)
• Table 170 China: DNA Sequencing Kits & Reagents Market, by Type, 2022-2031 (USD Million)
• Table 171 China: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
• Table 172 China: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 173 China: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 174 China: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 175 China: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 176 China: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 177 China: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 178 Japan: Key Macroindicators & Microindicators
• Table 179 Japan: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
• Table 180 Japan: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 181 Japan: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
• Table 182 Japan: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 183 Japan: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 184 Japan: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 185 Japan: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 186 Japan: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 187 Japan: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 188 INDIA: Key Macroindicators & Microindicators
• Table 189 India: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
• Table 190 India: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 191 India: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
• Table 192 India: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 193 India: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 194 India: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 195 India: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 196 India: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 197 India: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 198 Rest of Asia-Pacific: Estimated Number of New Cancer Cases, by Country, 2022 VS. 2030
• Table 199 Rest of Asia-Pacific: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
• Table 200 Rest of Asia-Pacific: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 201 Rest of Asia-Pacific: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
• Table 202 Rest of Asia-Pacific: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 203 Rest of Asia-Pacific: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 204 Rest of Asia-Pacific: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 205 Rest of Asia-Pacific: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 206 Rest of Asia-Pacific: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 207 Rest of Asia-Pacific: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 208 Latin America: DNA Sequencing Market, by Country/Region, 2022-2031 (USD Million)
• Table 209 Latin America: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
• Table 210 Latin America: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 211 Latin America: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
• Table 212 Latin America: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 213 Latin America: NGS-based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 214 Latin America: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 215 Latin America: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 216 Latin America: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 217 Latin America: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 218 Brazil: Key Macroindicators & Microindicators
• Table 219 Brazil: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
• Table 220 Brazil: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 221 Brazil: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
• Table 222 Brazil: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 223 Brazil: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 224 Brazil: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 225 Brazil: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 226 Brazil: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 227 Brazil: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 228 Mexico: Key Macroindicators & Microindicators
• Table 229 Mexico: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
• Table 230 Mexico: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 231 Mexico: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
• Table 232 Mexico: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 233 Mexico: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 234 Mexico: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 235 Mexico: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 236 Mexico: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 237 Mexico: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 238 Rest of Latin America: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
• Table 239 Rest of Latin America: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 240 Rest of Latin America: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
• Table 241 Rest of Latin America: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 242 Rest of Latin America: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 243 Rest of Latin America: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 244 Rest of Latin America: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 245 Rest of Latin America: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 246 Rest of Latin America: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 247 Middle East & Africa: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
• Table 248 Middle East & Africa: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
• Table 249 Middle East & Africa: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
• Table 250 Middle East & Africa: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 251 Middle East & Africa: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
• Table 252 Middle East & Africa: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
• Table 253 Middle East & Africa: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
• Table 254 Middle East & Africa: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
• Table 255 Middle East & Africa: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
• Table 256 Recent Developments, by Company (2021-2024)
• Table 257 Some of the Other Companies Operating in the DNA Sequencing Market

LIST OF FIGURES

• Figure 1 Research Process
• Figure 2 Secondary Sources Referenced for this Study
• Figure 3 Primary Research Techniques
• Figure 4 Key Executives Interviewed
• Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
• Figure 6 Market Sizing and Growth Forecast Approach
• Figure 7 Global DNA Sequencing Market, by Offering, 2024 VS. 2031 (USD Million)
• Figure 8 Global DNA Sequencing Market, by Technology, 2024 VS. 2031 (USD Million)
• Figure 9 Global DNA Sequencing Market, by Application, 2024 VS. 2031 (USD Million)
• Figure 10 Global DNA Sequencing Market, by End User, 2024 VS. 2031 (USD Million)
• Figure 11 Global DNA Sequencing Market, by Geography, 2024 VS. 2031 (USD Million)
• Figure 12 Impact Analysis of Market Drivers, Restraints, Opportunities, and Challenges (2024-2031)
• Figure 13 Share Of Cancer Cases, By Region, 2022 vs. 2040 (%)
• Figure 14 Genome Sequencing Costs, 2010-2021 (USD/GENOME)
• Figure 15 Pharmaceutical R&D Expenditures in The U.S., Europe, and China, 2010 VS. 2020 VS. 2021 (USD Million)
• Figure 16 Global Pharmaceutical R&D Expenditure, 2014-2028 (USD Billion)
• Figure 17 Percentage of Approved Personalized Medicines: Cancer VS. Rare Diseases VS. Other Diseases, 2022
• Figure 19 EU Regulatory Pathway - IVDR 2017/746
• Figure 20 China: Medical Device Classification and Premarket Requirements FOR IVD Products
• Figure 21 Porter's Five Forces Analysis
• Figure 22 Global DNA Sequencing Market, by offering, 2022 VS. 2031 (USD Million)
• Figure 23 Steps of Sample Preparation in A Typical Next-Generation DNA Sequencing Workflow
• Figure 24 Global DNA Sequencing Market, by Technology, 2024 VS. 2031 (USD Million)
• Figure 25 Steps of DNB Sequencing Technology Include
• Figure 26 Global DNA Sequencing Market, by Application, 2024 VS. 2031 (USD Million)
• Figure 27 U.S.: New Molecular Entity (NME) APPROVALS
• Figure 28 Estimated Number of New Cancer Cases (Million)
• Figure 29 Global DNA Sequencing Market, by End User, 2024 VS. 2031 (USD Million)
• Figure 30 Global Pharmaceutical R&D Spending, 2014-2028 (USD BILLION)
• Figure 31 Global DNA Sequencing Market, by Geography, 2024 VS. 2031 (USD Million)
• Figure 32 North America: DNA Sequencing Market Snapshot
• Figure 33 U.S.: Pharmaceutical R&D Expenditure, 2014-2022 (USD Billion)
• Figure 34 U.S.: Medical and Health R&D Investment Shares, by Source, 2020
• Figure 35 Research Funding Supported by The Canadian Genomics Enterprise, 2022-2023 (%)
• Figure 36 Genome Canada Funding Across Sectors, 2022-2023 (USD Million)
• Figure 37 Europe: Pharmaceutical Industry R&D Expenditure, 2000-2022 (USD Million)
• Figure 38 Europe: DNA Sequencing Market Snapshot
• Figure 39 Italy: Number of Biotechnology Firms, 2014-2022
• Figure 40 Italy: Number of Biotechnology R&D-Dedicated Firms, 2014-2022
• Figure 41 Rest of Europe: Pharmaceutical R&D Expenditure, 2021 (USD Million)
• Figure 42 Asia-Pacific: DNA Sequencing Market Snapshot
• Figure 43 Japan: Pharmaceutical Industry R&D Expenditure, 2014-2022 (USD Million)
• Figure 44 Japan: Number of New Molecular Entities Approved, 2014-2022
• Figure 45 Latin America: DNA Sequencing Market Snapshot
• Figure 46 Key Growth Strategies Adopted by Leading Players, 2021-2024
• Figure 47 DNA Sequencing Market: Competitive Benchmarking by offering
• Figure 48 DNA Sequencing Market: Competitive Benchmarking, by Region
• Figure 49 Competitive Dashboard: DNA Sequencing Market
• Figure 50 Global DNA Sequencing Market Share Analysis, by Key Players, 2023 (%)
• Figure 51 Illumina, Inc.: Financial SNAPSHOT (2023)
• Figure 52 Thermo Fisher Scientific Inc.: Financial Snapshot (2023)
• Figure 53 QIAGEN N.V: Financial Snapshot (2023)
• Figure 54 Agilent Technologies, Inc.: Financial Snapshot (2023)
• Figure 55 MGI Tech Co., Ltd.: Financial Snapshot (2023)
• Figure 56 F. Hoffmann-La Roche Ltd.: Financial Snapshot (2023)
• Figure 57 Revvity, Inc.: Financial Snapshot (2023)
• Figure 58 Pacific Biosciences of California Inc.: Financial Snapshot (2023)
• Figure 59 Danaher Corporation: Financial Snapshot (2023)
• Figure 60 Bio-Rad Laboratories, Inc.: Financial Snapshot (2023)
• Figure 61 Oxford Nanopore Technologies Plc.: Financial Snapshot (2023)

DNA Sequencing Market Size, Share, Forecast, & Trends Analysis by Offering (Kits & Reagents [DNA Extraction, Library Preparation, QC], Instruments, Software), Technology (NGS, Sanger), Application (Clinical, Research) End User-Global Forecast to 2031

The global DNA sequencing market is projected to reach $21.30 billion by 2031 at a CAGR of 11.8% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities.

The DNA sequencing market's growth is driven by several factors, including the decreasing costs of sequencing, the rising incidence of cancer and genetic disorders, the rising use of DNA sequencing in diagnostics and personalized medicine, increased pharmaceutical R&D investments, favorable regulatory and reimbursement policies, high healthcare expenditures, advances in sequencing technology, and supportive government initiatives aimed at promoting the use of sequencing technology in clinical & research applications. However, factors such as the high cost of sequencing consumables, limited identification of actionable mutations for precision medicine, and ethical and legal concerns related to DNA sequencing-based diagnostics restrain this growth.

Moreover, the expanding applications of DNA sequencing, government support for extensive genomic projects, growing awareness and adoption of targeted therapies, and economic growth in emerging markets are anticipated to offer growth opportunities for companies operating in this market. However, regulatory uncertainties, limited expertise & sequencing capabilities among smaller laboratories, a shortage of sequencing professionals in developing regions, and the substantial capital required for NGS infrastructure are some of the challenges impeding the market's growth.

Key trends in this market include the focus of emerging DNA sequencing companies on technological advancements and cost reduction and the emphasis by major players on developing portable and real-time sequencing technologies.

The report offers a competitive landscape based on an extensive assessment of the key players' product portfolios and geographical presence and the key growth strategies adopted by them over the past few years (2021-2024). The key players operating in the global DNA sequencing market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), and MGI Tech Co., Ltd. (China).

Among the offerings studied in this report, in 2024, the consumables segment is projected to dominate the DNA sequencing market, capturing 73.4% of the total share. The significant market share is attributed to the growing demand for consumables from end users, frequent use of sample preparation materials, increasing affordability, and the expansion of genome mapping programs.

Among the applications studied in this report, in 2024, the research & other applications segment is projected to dominate the DNA sequencing market, capturing 67.2% of the total share. The significant market share is attributed to several factors: the declining cost of sequencing procedures, increased R&D investments by pharmaceutical and biotechnology companies in drug discovery, the expanding use of NGS in various clinical and research settings, and the application of informatics solutions to identify pharmacological targets, validate therapeutic hypotheses, and assess the potential safety of inhibitory compounds targeting molecular sites.

Among the end users studied in this report, in 2024, the pharmaceutical & biotechnology companies segment is projected to dominate the DNA sequencing market, capturing 44.7% of the total share. The significant market share is attributed to increased R&D expenditures by pharmaceutical & biotechnology companies and the growing prevalence of chronic diseases, which are fueling the adoption of next-generation sequencing products.

An in-depth analysis of the geographical scenario of the global DNA sequencing market provides detailed qualitative and quantitative insights into five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is projected to dominate the market, capturing 49.0% of the total share. Additionally, in 2024, the U.S. is expected to dominate the DNA sequencing market in North America. The region's significant market share can be attributed to several factors, including supportive government initiatives for genomic research, expanding applications of sequencing-based studies, the presence of leading next-generation sequencing technology providers, rising research investments by pharmaceutical and biopharmaceutical companies, decreasing sequencing costs, wide availability of advanced sequencing products and solutions, increasing cancer prevalence, and a favorable reimbursement environment in the region.

Scope of the Report:

DNA Sequencing Market Assessment-by Offering

• Consumables
  • Sample Preparation Kits & Reagents
• DNA Extraction & Amplification
• Quality Control
• Other Kits & Reagents
  • Other Consumables
• Instruments
• Software
• Services

Note: Other Kits & Reagents Include dilution buffers, DNA standards, reagents for DNA cleanup, target enrichment, and other reagents

DNA Sequencing Market Assessment -by Technology

• Next-Generation Sequencing
  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • DNA Nanoball Sequencing
  • Single-molecule Real-time Sequencing
  • Other NGS Technologies
• Sanger Sequencing & Pyrosequencing

Note: Other NGS Technologies Nanopore Sequencing and AVITI Sequencing

DNA Sequencing Market Assessment -by Application

• Research & Other Applications
  • Drug Discovery
  • Agriculture & Animal Research
  • Other Applications
• Clinical Applications
  • Reproductive Health
  • Oncology
  • Infectious Diseases
  • Other Clinical Applications

Note: Other Applications include food microbiology, microbiota analysis in the beverage industry, and environmental studies.

Note: Other Clinical Applications include the detection of genetic aberrations in neurological disorders, rare diseases, and metabolic and immune disorders.

DNA Sequencing Market Assessment-by End User

• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Laboratories
• Academic Institutes & Research Centers
• Other End Users

Note: Other End Users include forensic laboratories & security agencies, food & beverage companies, and agriculture companies.

DNA Sequencing Market Assessment-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • Italy
  • U.K.
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific
  • China
  • Japan
  • India
  • Rest of Asia-Pacific (RoAPAC)
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America (RoLATAM)
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition & Scope
• 1.2. Market Ecosystem
• 1.3. Currency & Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Process
• 2.2. Process of Data Collection & Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of The Industry
• 2.3. Market Sizing and Forecast
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
  • 2.3.3. Market Share Analysis
• 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Factors Affecting Market Growth
  • 4.2.1. Impact Analysis of Market Dynamics
  • 4.2.2. Factor Analysis
• 4.3. Pricing Analysis
• 4.4. Industry Trends
  • 4.4.1. Emerging DNA Sequencing Companies' Focus on Improving Technologies and Reducing Costs
    • 4.4.1.1. Singular Genomics Systems, Inc. (U.S.)
    • 4.4.1.2. Ultima Genomics, Inc. (U.S.)
    • 4.4.1.3. Element Biosciences (U.S.)
  • 4.4.2. Key Market Players' Emphasis on PorTable and Real-Time Sequencing Technologies
• 4.5. Regulatory Analysis
  • 4.5.1. North America
    • 4.5.1.1. U.S.
    • 4.5.1.2. Canada
  • 4.5.2. Europe
  • 4.5.3. Asia-Pacific
    • 4.5.3.1. China
    • 4.5.3.2. Japan
    • 4.5.3.3. India
  • 4.5.4. Latin America
  • 4.5.5. Middle East
• 4.6. Porter's Five Forces Analysis

5. DNA Sequencing Market Assessment-by Offering

• 5.1. Overview
• 5.2. Consumables
  • 5.2.1. Sample Preparation Kits & Reagents
    • 5.2.1.1. Library Preparation
    • 5.2.1.2. DNA Extraction & Amplification
    • 5.2.1.3. Quality Control
    • 5.2.1.4. Other Kits & Reagents
  • 5.2.2. Other Consumables
• 5.3. Instruments
• 5.4. Software
• 5.5. Services

6. Global DNA Sequencing Market Assessment-by Technology

• 6.1. Overview
• 6.2. Next-generation Sequencing
  • 6.2.1. Sequencing by Synthesis
  • 6.2.2. Ion Semiconductor Sequencing
  • 6.2.3. Single-molecule Real-Time Sequencing
  • 6.2.4. DNA Nanoball Sequencing
  • 6.2.5. Other NGS Sequencing Technologies
• 6.3. Sanger Sequencing & Pyrosequencing

7. DNA Sequencing Market Assessment-by Application

• 7.1. Overview
• 7.2. Research & Other Applications
  • 7.2.1. Drug Discovery
  • 7.2.2. Agricultural & Animal Research
  • 7.2.3. Other Applications
• 7.3. Clinical Applications
  • 7.3.1. Oncology
  • 7.3.2. Reproductive Health
  • 7.3.3. Infectious Diseases
  • 7.3.4. Other Clinical Applications

8. DNA Sequencing Market Assessment-by End User

• 8.1. Overview
• 8.2. Pharmaceutical & Biotechnology Companies
• 8.3. Hospitals & Diagnostic Laboratories
• 8.4. Academic & Research Institutes
• 8.5. Other End Users

9. DNA Sequencing Market Assessment-by Geography

• 9.1. Overview
• 9.2. North America
  • 9.2.1. U.S.
  • 9.2.2. Canada
• 9.3. Europe
  • 9.3.1. Germany
  • 9.3.2. France
  • 9.3.3. U.K.
  • 9.3.4. Italy
  • 9.3.5. Spain
  • 9.3.6. Rest of Europe (ROE)
• 9.4. Asia-Pacific
  • 9.4.1. China
  • 9.4.2. Japan
  • 9.4.3. India
  • 9.4.4. Rest of Asia-Pacific (ROAPAC)
• 9.5. Latin America
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America (ROLATAM)
• 9.6. Middle East & Africa (MEA)

10. Competition Analysis

• 10.1. Overview
• 10.2. Key Growth Strategies
• 10.3. Competitive Benchmarking
• 10.4. Competitive Dashboard
  • 10.4.1. Industry Leaders
  • 10.4.2. Market Differentiators
  • 10.4.3. Vanguards
  • 10.4.4. Emerging Companies
• 10.5. Market Share Analysis (2023)
  • 10.5.1. Illumina, Inc. (U.S.)
  • 10.5.2. Thermo Fisher Scientific Inc. (U.S.)
  • 10.5.3. MGI Tech Co., Ltd. (China)
  • 10.5.4. Agilent Technologies, Inc. (U.S.)
  • 10.5.5. QIAGEN N.V. (Netherlands)

11. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis)

• 11.1. Illumina, Inc. (U.S.)
• 11.2. Thermo Fisher Scientific Inc.
• 11.3. QIAGEN N.V.
• 11.4. Agilent Technologies, Inc.
• 11.5. MGI Tech Co., Ltd.
• 11.6. F. Hoffmann-La Roche Ltd
• 11.7. Revvity, Inc.
• 11.8. Pacific Biosciences of California Inc.
• 11.9. Danaher Corporation
• 11.10. Bio-Rad Laboratories, Inc.
• 11.11. Oxford Nanopore Technologies Plc.
• 11.12. Other Companies

12. Appendix

• 12.1. Available Customization
• 12.2. Related Reports